FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S. - CNBC
- FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S. CNBC
- Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease | Eli Lilly and Company Investors | Eli Lilly and Company
- Eli Lilly (LLY) Alzheimer’s Disease Drug Wins FDA Approval Bloomberg
- America gets another Alzheimer's drug in its arsenal: FDA approves Eli Lilly's treatment which slows symptoms Daily Mail
- FDA greenlights Lilly's Kisunla for early Alzheimer's FirstWord Pharma